ABVXABIVAX Société Anonyme
What is the market doing?
No clear lean: nothing decisive, though in a downtrend (−24% vs 200-day).
In a downtrend, below its 50- and 200-day averages. Oversold (RSI 29). Price is −24% vs its 200-day average.
Heavily shorted, settled Sep 15, 2026, about a week of normal trading to cover. Down 1.5% since the previous count, up from 6.7% of shares outstanding three months ago.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ABVX is trading
ABIVAX Société Anonyme is +7.0% over the past year while the S&P 500 is +18%: 11 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −24%
vs 200-day average · a clear downtrend
- RSI (14)
- 29
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 39%
Below its 52-week high
Details›
- Last close2026-10-09
- $88.10
- 1 monthS&P 500 +2.7%
- −24%
- 1 yearS&P 500 +18%
- +7.0%
- vs 50-day average$111.00
- −21%
- 52-week high
- $145.31
- 52-week low
- $72.50
- Annualised volatility
- 422%
| Year | Return |
|---|---|
| 2026 (year to date) | −35% |
| 2025 | +1742% |
| 2024 | −32% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 3 | 1 of 3 | −4.3% |
| Feb | 3 | 3 of 3 | +14% |
| Mar | 3 | 1 of 3 | −7.2% |
| Apr | 3 | 3 of 3 | +8.1% |
| May | 3 | 1 of 3 | −3.0% |
| Jun | 3 | 1 of 3 | −3.0% |
| Jul | 3 | 2 of 3 | +287% |
| Aug | 3 | 2 of 3 | +3.5% |
| Sep | 3 | 1 of 3 | −5.3% |
| Oct | 3 | 1 of 3 | −0.28% |
| Nov | 3 | 2 of 3 | +5.0% |
| Dec | 3 | 2 of 3 | −0.25% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.